Sumi Eriko

スミエリコ | Sumi Eriko

Affiliation and department：

Research field (1)： Medical equipment testing

Research theme for competitive and other funds (3)：

2019 - 2021 Measures to use immunosuppressive agents properly in regenerative medicine
2011 - 2012 Development and evaluation of a clinical trial simulation system by the second use of EMRs
2007 - 2008 The Consolidation of Ethical Infrastructures Supporting Clinical Trials for the Development of Advanced Medicine Technology

Papers (37)：

角栄里子, 猪原登志子. 移植を対象とした免疫抑制剤の承認時評価に関する研究. 臨床薬理. 2020. 51. Suppl. S346-S346
Sumi Eriko, Matsuda Shuichi. Precision medicine at Academic research organization, iACT. Precision Medicine. 2020. 3. 12. 1118-1121
Motohiro Itoi, Mayumi Ueta, Ken Ogino, Eriko Sumi, Kojiro Imai, Satoshi Teramukai, Shigeru Kinoshita, Chie Sotozono. Clinical trial to evaluate the therapeutic benefits of limbal-supported contact lens wear for ocular sequelae due to Stevens-Johnson syndrome/toxic epidermal necrolysis. Contact lens & anterior eye : the journal of the British Contact Lens Association. 2020. 43. 6. 535-542
Eriko Sumi, Ryuta Asada, Ying Lu, Toshiko Ito-Ihara, Kevin V Grimes. A Qualitative Study on the Differences Between Trial Populations and the Approved Therapeutic Indications of Antineoplastic Agents by 3 Regulatory Agencies From 2010 to 2018. Clinical therapeutics. 2020
Hanako Ohashi Ikeda, Yuki Muraoka, Masayuki Hata, Eriko Sumi, Takafumi Ikeda, Takayuki Nakagawa, Hiroyasu Abe, Harue Tada, Satoshi Morita, Akira Kakizuka, et al. Safety and effectiveness of a novel neuroprotectant, KUS121, in patients with non-arteritic central retinal artery occlusion: An open-label, non-randomized, first-in-humans, phase 1/2 trial. PloS one. 2020. 15. 2. e0229068

ｍore...

MISC (27)：

ｍore...

Lectures and oral presentations (25)：

異分野融合型シーズの類型化
(日本臨床試験学会第11回学術集会総会 2020)
Acceleration of translational research from basic study to clinical trial at the iACT, Kyoto University Hosipital.
(The 2nd KYOTO-SPARK Symposium Value of Academic Translational Research 2018)
Contract manufacturing and shelf life estimation of investigational drugs
(2017)
Mission and Accomplishments of iACT
(The 1st KYOTO-SPARKsymposium Construction of a Drug Discovery Ecosystem between Academia-Pharma 2017)
Preparation of oncolytic virus as an investigational drug
(Academic Research Organization Council The 4th Annual Meeting 2016)

ｍore...

Professional career (1)：

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page